NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$15.29
Tradestie Score
49
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
+29.0%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$65.11
|
$3.26B | - | 63 | Compare |
|
VCYT
Veracyte, Inc.
|
$46.32
|
$2.85B | 51.6 | 51 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$68.56
|
$2.24B | - | 51 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$22.57
|
$2.22B | - | 59 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$91.55
|
$1.77B | - | 54 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$14.84
|
$1.56B | - | 45 | Compare |
|
NEOG
Neogen Corp
|
$12.04
|
$1.26B | - | 58 | Compare |
|
OPK
Opko Health Inc.
|
$1.32
|
$1.23B | - | 50 | Compare |
|
CDNA
CareDx, Inc.
|
$43.71
|
$798.40M | - | 45 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$16.55
|
$719.31M | - | 54 | Compare |
More NEO Analysis
Data updated: Aug 02, 2026 | Industry: Diagnostics & Research (SIC 8734)
36 stocks in this industry